202 related articles for article (PubMed ID: 35832080)
1. Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study.
Liu ZC; Wu WH; Huang S; Li ZW; Li X; Shui GH; Lam SM; Li BW; Li ZX; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
Theranostics; 2022; 12(10):4671-4683. PubMed ID: 35832080
[No Abstract] [Full Text] [Related]
2. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer.
Li X; Zheng NR; Wang LH; Li ZW; Liu ZC; Fan H; Wang Y; Dai J; Ni XT; Wei X; Liu MW; Li K; Li ZX; Zhou T; Zhang Y; Zhang JY; Kadeerhan G; Huang S; Wu WH; Liu WD; Wu XZ; Zhang LF; Xu JM; Gerhard M; You WC; Pan KF; Li WQ; Qin J
EBioMedicine; 2021 Dec; 74():103714. PubMed ID: 34818622
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
4. Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.
Fan H; Li X; Li ZW; Zheng NR; Cao LH; Liu ZC; Liu MW; Li K; Wu WH; Li ZX; Zhou T; Zhang Y; Liu WD; Zhang LF; You WC; Wang Y; Wu J; Pan KF; Qin J; Li WQ
EBioMedicine; 2022 Dec; 86():104340. PubMed ID: 36356476
[TBL] [Abstract][Full Text] [Related]
5. [The risk of incident gastric cancer for populations with different precancerous gastric lesions: a prospective follow-up study].
Wu XZ; Liu ZC; Qin XX; Li Y; Zhang LF; Li ZX; Zhang Y; Zhou T; Zhang JY; Liu WD; You WC; Pan KF; Li WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Dec; 43(12):1972-1978. PubMed ID: 36572472
[No Abstract] [Full Text] [Related]
6. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
7. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.
Hu H; Zhang Y; Zou M; Yang S; Liang XQ
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1407-14. PubMed ID: 20127252
[TBL] [Abstract][Full Text] [Related]
8. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.
Zhang LY; Zhang J; Li D; Liu Y; Zhang DL; Liu CF; Wang N; Wu SR; Lu WQ; Guo JZ; Shi YQ
J Dig Dis; 2021 May; 22(5):282-290. PubMed ID: 33793080
[TBL] [Abstract][Full Text] [Related]
9. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
10. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
11. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer.
Chen J; Wu L; Sun Y; Yin Q; Chen X; Liang S; Meng Q; Long H; Li F; Luo C; Xiao X
PeerJ; 2019; 7():e7002. PubMed ID: 31245174
[TBL] [Abstract][Full Text] [Related]
12. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
[TBL] [Abstract][Full Text] [Related]
13. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer.
You WC; Li JY; Blot WJ; Chang YS; Jin ML; Gail MH; Zhang L; Liu WD; Ma JL; Hu YR; Mark SD; Correa P; Fraumeni JF; Xu GW
Int J Cancer; 1999 Nov; 83(5):615-9. PubMed ID: 10521796
[TBL] [Abstract][Full Text] [Related]
14. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
15. Serum peptide mapping in gastric precancerous lesion and cancer.
Li P; Ma D; Zhu ST; Tang XD; Zhang ST
J Dig Dis; 2014 May; 15(5):239-45. PubMed ID: 24438315
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
18. Associations of the -238(G/A) and -308(G/A) TNF-α Promoter Polymorphisms and TNF-α Serum Levels with the Susceptibility to Gastric Precancerous Lesions and Gastric Cancer Related to Helicobacter pylori Infection in a Moroccan Population.
Bounder G; Jouimyi MR; Boura H; Touati E; Michel V; Badre W; Jouhadi H; Kadi M; Eljihad M; Benomar H; Kettani A; Lebrazi H; Maachi F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1623-1629. PubMed ID: 32592356
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population.
Boreiri M; Samadi F; Etemadi A; Babaei M; Ahmadi E; Sharifi AH; Nikmanesh A; Houshiar A; Pourfarzai F; Yazdanbod A; Alimohammadian M; Sotoudeh M
Arch Iran Med; 2013 Jun; 16(6):343-7. PubMed ID: 23725067
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions.
Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW
World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
